Golden Retriever Lifetime Study
Morris Animal Foundation's Golden Retriever Lifetime Study will help identify major nutritional, genetic and environmental risk factors for cancer and other important diseasesin dogs.
Displaying 1 - 7 of 42 Results
Evaluating a Novel Adjunct Treatment for Hemangiosarcoma
Researchers will determine if common heart medications are an effective adjunct therapy for dogs with hemangiosarcoma.
Improving Management of Lymphocytic Leukemia
Researchers will identify potential treatment targets for B-cell chronic lymphocytic leukemia in dogs and ways to identify high-risk patients.
Understanding Metabolic Drivers of Osteosarcoma Tumors
Researchers will explore metabolic drivers of cancer growth and look for new therapy targets for osteosarcoma, the most common type of bone cancer in dogs.
Exploring the Broader Application of a New Cancer Drug
Researchers will determine if a promising new drug used to treat dogs with hemangiosarcoma would benefit dogs with other incurable cancers.
Finding Ways to Block Hemangiosarcoma Tumor Growth
Researchers will investigate how hemangiosarcoma cells use cholesterol and lipids to promote tumor growth and look at ways to block tumor cells from using these metabolic fuels.
Evaluating a New Treatment for Oral Cancer
Researchers will investigate a new and promising treatment for oral squamous cell carcinoma, the most common oral cancer in cats.